Devic Syndrome
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders (NCT02249676) | Tianjin Medical University General Hospital | 2013-01-01 |
Track Devic Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.